Zobrazeno 1 - 10
of 11 152
pro vyhledávání: '"Tak, Pp"'
Autor:
Aranow C; Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York, USA caranow@northwell.edu., Allaart CF; Leids Universitair Medisch Centrum, Leiden, The Netherlands., Amoura Z; Assistance Publique-Hôpitaux de Paris, Groupement Hospitalier Pitié-Salpêtrière, French National Referral Center for Systemic Lupus Erythematosus, Antiphospholipid Antibody Syndrome and Other Autoimmune Disorders, Service de Médecine Interne 2, Institut E3M, Inserm UMRS, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Sorbonne Université, Paris, France., Bruce IN; Kellgren Centre for Rheumatology, Manchester University Hospitals NHS Trust, Manchester, UK.; Centre for Musculoskeletal Research, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK., Cagnoli PC; University of Michigan Medical Center, Ann Arbor, Michigan, USA., Chatham WW; University of Alabama at Birmingham, Birmingham, Alabama, USA., Clark KL; Clinical Science, GSK, Stevenage, UK., Furie R; Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York, USA., Groark J; Clinical Development, GSK, Collegeville, Pennsylvania, USA., Urowitz MB; Toronto Western Hospital, University of Toronto, Lupus Clinic, Toronto, Ontario, Canada., van Vollenhoven R; Amsterdam University Medical Center, Amsterdam Rheumatology Center, Amsterdam, The Netherlands., Daniels M; Global Medical Affairs, GSK, Brentford, UK., Fox NL; Clinical Development, GSK, Collegeville, Pennsylvania, USA., Gregan YI; Clinical Science Immunology, GSK, Collegeville, Pennsylvania, USA., Henderson RB; Clinical Biomarker Group, GSK, Stevenage, UK., van Maurik A; Clinical Biomarker Group, GSK, Stevenage, UK., Ocran-Appiah JC; Clinical Science, Respiratory and Immunology Clinical Research and Early Programs, GSK, Philadelphia, Pennsylvania, USA., Oldham M; Biostatistics, GSK, Stevenage, UK., Roth DA; Research and Development, GSK, Collegeville, Pennsylvania, USA., Shanahan D; Development Biostatistics, GSK, GSK House, Brentford, UK., Tak PP; Research and Development, GSK, Stevenage, UK., Teng YO; Department of Nephrology, Leiden University Medical Center, Leiden, The Netherlands.
Publikováno v:
Annals of the rheumatic diseases [Ann Rheum Dis] 2024 Oct 21; Vol. 83 (11), pp. 1502-1512. Date of Electronic Publication: 2024 Oct 21.
Autor:
Frazzei G; Department of Rheumatology and Clinical Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Amsterdam Rheumatology and Immunology Center, Amsterdam, The Netherlands., Cramer SHM; Department of Rheumatology and Clinical Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Landewé RBM; Department of Rheumatology and Clinical Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Amsterdam Rheumatology and Immunology Center, Amsterdam, The Netherlands.; Rheumatology, Zuyderland MC, Heerlen, The Netherlands., Maijer KI; Dermatology, Tergooi Hospital, Hilversum, The Netherlands., Gerlag DM; Department of Rheumatology and Clinical Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; UCB Pharma Ltd, Slough, UK., Tak PP; Department of Rheumatology and Clinical Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Candel Therapeutics, Needham, Massachusetts, USA.; Research and Development, GSK, Stevenage, UK., de Vries N; Department of Rheumatology and Clinical Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Amsterdam Rheumatology and Immunology Center, Amsterdam, The Netherlands., van Baarsen LGM; Department of Rheumatology and Clinical Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Amsterdam Rheumatology and Immunology Center, Amsterdam, The Netherlands., van Vollenhoven RF; Department of Rheumatology and Clinical Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Amsterdam Rheumatology and Immunology Center, Amsterdam, The Netherlands., Tas SW; Department of Rheumatology and Clinical Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands s.w.tas@amsterdamumc.nl.; Amsterdam Rheumatology and Immunology Center, Amsterdam, The Netherlands.
Publikováno v:
RMD open [RMD Open] 2024 Oct 18; Vol. 10 (4). Date of Electronic Publication: 2024 Oct 18.
Autor:
Myasoedova E; Mayo Clinic, Rochester, Minnesota., Athreya AP; Mayo Clinic, Rochester, Minnesota., Crowson CS; Mayo Clinic, Rochester, Minnesota., Davis JM 3rd; Mayo Clinic, Rochester, Minnesota., Warrington KJ; Mayo Clinic, Rochester, Minnesota., Walchak RC; Mayo Clinic, Rochester, Minnesota., Carlson E; Mayo Clinic, Rochester, Minnesota., Kalari KR; Mayo Clinic, Rochester, Minnesota., Bongartz T; Vanderbilt Medical Center, Nashville, Tennessee., Tak PP; Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands, and Candel Therapeutics, Needham, Massachusetts., van Vollenhoven RF; Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands., Padyukov L; Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden., Emery P; University of Leeds and NIHR Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Morgan A; University of Leeds and NIHR Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Wang L; Mayo Clinic, Rochester, Minnesota., Weinshilboum RM; Mayo Clinic, Rochester, Minnesota., Matteson EL; Mayo Clinic, Rochester, Minnesota.
Publikováno v:
Arthritis care & research [Arthritis Care Res (Hoboken)] 2022 Jun; Vol. 74 (6), pp. 879-888. Date of Electronic Publication: 2022 Apr 06.
Autor:
Ling AL; Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA., Solomon IH; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Department of Pathology, Dana-Farber Cancer Institute, Boston, MA, USA., Landivar AM; Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA., Nakashima H; Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA., Woods JK; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Department of Pathology, Dana-Farber Cancer Institute, Boston, MA, USA., Santos A; Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Department of Pathology, Dana-Farber Cancer Institute, Boston, MA, USA., Masud N; Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA., Fell G; Department of Biostatistics, Dana-Farber Cancer Institute, Boston, MA, USA., Mo X; Center for Biostatistics, Department of Biomedical Informatics, The Ohio State University, Columbus, OH, USA.; James Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA., Yilmaz AS; Center for Biostatistics, Department of Biomedical Informatics, The Ohio State University, Columbus, OH, USA.; James Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA., Grant J; Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA., Zhang A; Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA., Bernstock JD; Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA., Torio E; Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA., Ito H; Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA., Liu J; Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA., Shono N; Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA., Nowicki MO; Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA., Triggs D; Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA., Halloran P; Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA., Piranlioglu R; Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA., Soni H; Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA., Stopa B; Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA., Bi WL; Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA., Peruzzi P; Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA., Chen E; Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA., Malinowski SW; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Department of Pathology, Dana-Farber Cancer Institute, Boston, MA, USA., Prabhu MC; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Department of Pathology, Dana-Farber Cancer Institute, Boston, MA, USA., Zeng Y; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Department of Pathology, Dana-Farber Cancer Institute, Boston, MA, USA., Carlisle A; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Rodig SJ; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Department of Pathology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Wen PY; Center for Neuro-oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Lee EQ; Center for Neuro-oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Nayak L; Center for Neuro-oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Chukwueke U; Center for Neuro-oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Gonzalez Castro LN; Center for Neuro-oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA., Dumont SD; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Batchelor T; Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA., Kittelberger K; ClearPoint Neuro, Solana Beach, CA, USA., Tikhonova E; BostonGene, Waltham, MA, USA., Miheecheva N; BostonGene, Waltham, MA, USA., Tabakov D; BostonGene, Waltham, MA, USA., Shin N; BostonGene, Waltham, MA, USA., Gorbacheva A; BostonGene, Waltham, MA, USA., Shumskiy A; BostonGene, Waltham, MA, USA., Frenkel F; BostonGene, Waltham, MA, USA., Aguilar-Cordova E; Candel Therapeutics, Needham, MA, USA., Aguilar LK; Candel Therapeutics, Needham, MA, USA., Krisky D; Candel Therapeutics, Needham, MA, USA., Wechuck J; Candel Therapeutics, Needham, MA, USA., Manzanera A; Candel Therapeutics, Needham, MA, USA., Matheny C; Candel Therapeutics, Needham, MA, USA., Tak PP; Candel Therapeutics, Needham, MA, USA., Barone F; Candel Therapeutics, Needham, MA, USA., Kovarsky D; Department of Molecular Cell Biology, Weizmann Institute of Medical Sciences, Tel Aviv, Israel., Tirosh I; Department of Molecular Cell Biology, Weizmann Institute of Medical Sciences, Tel Aviv, Israel., Suvà ML; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Wucherpfennig KW; Department of Cancer Immunology and Virology, Dana Farber Cancer Institute, Boston, MA, USA., Ligon K; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Department of Pathology, Dana-Farber Cancer Institute, Boston, MA, USA., Reardon DA; Center for Neuro-oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Chiocca EA; Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA. eachiocca@bwh.harvard.edu.
Publikováno v:
Nature [Nature] 2023 Nov; Vol. 623 (7985), pp. 157-166. Date of Electronic Publication: 2023 Oct 18.
Autor:
Koch MS; Harvey Cushing Neurooncology Research Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States., Zdioruk M; Harvey Cushing Neurooncology Research Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States., Nowicki MO; Harvey Cushing Neurooncology Research Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States., Hoetker MS; Department of Molecular Biology, Massachusetts General Hospital, Boston, MA, United States., Herbert ZT; Molecular Biology Core Facilities, Dana-Farber Cancer Institute, Boston, MA, United States., Barone F; Candel Therapeutics, Needham, MA, United States., Tak PP; Candel Therapeutics, Needham, MA, United States., Chiocca EA; Harvey Cushing Neurooncology Research Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States., Tabatabai G; Department of Neurology and Interdisciplinary Neuro-Oncology, University Hospital Tübingen, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen, Tübingen, Germany., Lawler SE; Harvey Cushing Neurooncology Research Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.; Department of Pathology and Laboratory Medicine, Legorreta Cancer Center, Brown University, Providence, RI, United States.
Publikováno v:
Frontiers in medicine [Front Med (Lausanne)] 2023 May 09; Vol. 10, pp. 1140352. Date of Electronic Publication: 2023 May 09 (Print Publication: 2023).
Autor:
Koopman, F, Musters, A, Backer, M, Gerlag, D, Miljko, S, Grazio, Simeon, Sokolović, Š, Levine, Y, Glass, E Chernoff D, De Vries N, Tak PP
Background: Rheumatoid arthritis (RA) is a disease with significant remaining unmet medical needs for better treatments. Vagus nerve stimulation (VNS) to activate the inflammatory reflex (cholinergic anti-inflammatory pathway) repre sents a novel exp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::048bf084fbc5154330370b829c195cc1
https://doi.org/0.1136/annrheumdis-2020-eular.2914
https://doi.org/0.1136/annrheumdis-2020-eular.2914
Autor:
Korchynskyi O; Department of Human Immunology and Centre for Innovative Biomedical Research, Medical Faculty, University of Rzeszow, 1a Warzywna St., 35-310 Rzeszów, Poland.; Department of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.; Department of Molecular Immunology, Palladin Institute of Biochemistry, National Academy of Sciences of Ukraine, 01054 Kyiv, Ukraine.; Department of Public Development and Health, S. Gzhytskyi National University of Veterinary Medicine and Biotechnologies, 79010 Lviv, Ukraine., Yoshida K; Division of Rheumatology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.; Division of Rheumatology, Department of Internal Medicine, the Jikei University School of Medicine, Tokyo 105-8461, Japan., Korchynska N; Department of Public Development and Health, S. Gzhytskyi National University of Veterinary Medicine and Biotechnologies, 79010 Lviv, Ukraine., Czarnik-Kwaśniak J; Department of Human Immunology and Centre for Innovative Biomedical Research, Medical Faculty, University of Rzeszow, 1a Warzywna St., 35-310 Rzeszów, Poland., Tak PP; Department of Internal Medicine, University of Cambridge, Cambridge CB2 1TN, UK.; Candel Therapeutics, Needham, MA 02494, USA., Pruijn GJM; Department of Biomolecular Chemistry, Institute for Molecules and Materials, Radboud University, 6525 AJ Nijmegen, The Netherlands., Isozaki T; Division of Rheumatology, University of Michigan Medical School, Ann Arbor, MI 48109, USA., Ruth JH; Division of Rheumatology, University of Michigan Medical School, Ann Arbor, MI 48109, USA., Campbell PL; Division of Rheumatology, University of Michigan Medical School, Ann Arbor, MI 48109, USA., Amin MA; Division of Rheumatology, University of Michigan Medical School, Ann Arbor, MI 48109, USA., Koch AE; Division of Rheumatology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2023 Jan 18; Vol. 24 (3). Date of Electronic Publication: 2023 Jan 18.
Autor:
Mariette X; Department of Rheumatology, Université Paris-Saclay, Hôpital Bicêtre, Assistance Publique - Hôpitaux de Paris, INSERM UMR1184, Le Kremlin Bicêtre, Paris, France., Barone F; Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom., Baldini C; Centro Farmacologia Clinica AOUP, Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy., Bootsma H; Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Clark KL; Clinical Science, GSK, Stevenage, Hertfordshire, United Kingdom., De Vita S; Rheumatology Clinic, Department of Medical Area, Azienda Ospedaliera Universitaria di Udine, Udine, Italy., Gardner DH; Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom., Henderson RB; Clinical Pharmacology and Experimental Medicine, GSK, Stevenage, Hertfordshire, United Kingdom., Herdman M; Clinical Pharmacology and Experimental Medicine, GSK, Stevenage, Hertfordshire, United Kingdom., Lerang K; Department of Rheumatology, Oslo University Hospital, Oslo, Norway., Mistry P; R&D Biostatistics, GSK, Stevenage, Hertfordshire, United Kingdom., Punwaney R; Pharmaceutical Research and Development, GSK, Collegeville, Pennsylvania, USA., Seror R; Department of Rheumatology, Université Paris-Saclay, Hôpital Bicêtre, Assistance Publique - Hôpitaux de Paris, INSERM UMR1184, Le Kremlin Bicêtre, Paris, France., Stone J; R&D, GSK, Stevenage, Hertfordshire, United Kingdom., van Daele P; Department of Internal Medicine and Department of Immunology, Erasmus Medical Center, Rotterdam, The Netherlands., van Maurik A; Clinical Pharmacology and Experimental Medicine, GSK, Stevenage, Hertfordshire, United Kingdom., Wisniacki N; Discovery Medicine, GSK, Stevenage, Hertfordshire, United Kingdom., Roth DA; R&D, GSK, Collegeville, Pennsylvania, USA., Tak PP; R&D, GSK, Stevenage, Hertfordshire, United Kingdom.
Publikováno v:
JCI insight [JCI Insight] 2022 Dec 08; Vol. 7 (23). Date of Electronic Publication: 2022 Dec 08.
Autor:
de Jong TA; Amsterdam UMC, University of Amsterdam, Department of Rheumatology & Clinical Immunology and Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam, Netherlands; Amsterdam Rheumatology & Immunology Center (ARC), Academic Medical Center, Amsterdam, Netherlands., de Hair MJH; Amsterdam UMC, University of Amsterdam, Department of Rheumatology & Clinical Immunology and Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam, Netherlands., van de Sande MGH; Amsterdam UMC, University of Amsterdam, Department of Rheumatology & Clinical Immunology and Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam, Netherlands; Amsterdam Rheumatology & Immunology Center (ARC), Academic Medical Center, Amsterdam, Netherlands., Semmelink JF; Amsterdam UMC, University of Amsterdam, Department of Rheumatology & Clinical Immunology and Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam, Netherlands; Amsterdam Rheumatology & Immunology Center (ARC), Academic Medical Center, Amsterdam, Netherlands., Choi IY; Amsterdam UMC, University of Amsterdam, Department of Rheumatology & Clinical Immunology and Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam, Netherlands; Amsterdam Rheumatology & Immunology Center (ARC), Academic Medical Center, Amsterdam, Netherlands., Gerlag DM; Amsterdam UMC, University of Amsterdam, Department of Rheumatology & Clinical Immunology and Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam, Netherlands; UCB Pharma, Slough SL1 3XE, UK., Tak PP; Amsterdam UMC, University of Amsterdam, Department of Rheumatology & Clinical Immunology and Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam, Netherlands; Candel Therapeutics, Needham, MA, USA; Internal Medicine, Cambridge University, Cambridge, CB2 1TN, UK., van Baarsen LGM; Amsterdam UMC, University of Amsterdam, Department of Rheumatology & Clinical Immunology and Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam, Netherlands; Amsterdam Rheumatology & Immunology Center (ARC), Academic Medical Center, Amsterdam, Netherlands. Electronic address: e.g.vanbaarsen@amsterdamumc.nl.
Publikováno v:
Journal of autoimmunity [J Autoimmun] 2022 Dec; Vol. 133, pp. 102923. Date of Electronic Publication: 2022 Oct 06.
Autor:
Tak PP, Gerlag DM, Garrelfs M, de Launay D, Garcia-Perez S, van Baarsen LGM, Frleta M, Reedquist KA
Publikováno v:
Pediatric Rheumatology Online Journal, Vol 9, Iss Suppl 1, p P278 (2011)
Externí odkaz:
https://doaj.org/article/e2aaf398b2e844b9a4bfb609c622d3bd